Pharmaron Appoints New Board Members Including Executive Directors Lou Boliang and Lou Xiaoqiang
Stock News
Jun 12
Pharmaron (HKEX: 03759) has announced the results of its annual general meeting, where shareholders passed resolutions to appoint new members to the company's board of directors.
Following the shareholder vote, Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been appointed as executive directors for the fourth term of the board.
Additionally, Ms. Wan Xuan has been appointed as a non-executive director.
The appointments of Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong as independent non-executive directors for the fourth board term were also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.